Harmony Biosciences Holdings Inc’s filing revealed that its CHIEF COMMERCIAL OFFICER Dierks Jeffrey unloaded Company’s shares for reported $0.16 million on Mar 03 ’25. In the deal valued at $32.67 per share,4,869 shares were sold. As a result of this transaction, Dierks Jeffrey now holds 0 shares worth roughly $0.0.
Then, JEFFREY G DIERKS bought 4,869 shares, generating $164,816 in total proceeds.
Before that, Dierks Jeffrey sold 13,125 shares. Harmony Biosciences Holdings Inc shares valued at $489,634 were divested by the CHIEF COMMERCIAL OFFICER at a price of $37.31 per share. As a result of the transaction, Dierks Jeffrey now holds 0 shares, worth roughly $0.0.
Deutsche Bank initiated its Harmony Biosciences Holdings Inc [HRMY] rating to a Buy in a research note published on February 11, 2025; the price target was $55. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid December with a ‘”a Buy”‘ rating. UBS started covering the stock on September 10, 2024. It rated HRMY as “a Buy”.
Price Performance Review of HRMY
On Tuesday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock jump 1.34% to $34.78. Over the last five days, the stock has gained 3.36%. Harmony Biosciences Holdings Inc shares have risen nearly 1.08% since the year began. Nevertheless, the stocks have risen 10.91% over the past one year. While a 52-week high of $41.61 was reached on 01/21/25, a 52-week low of $28.14 was recorded on 03/04/25. SMA at 50 days reached $36.23, while 200 days put it at $34.60.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 34.07, which if violated will result in even more drops to 33.35. On the upside, there is a resistance level at 35.38. A further resistance level may holdings at 35.97. The Relative Strength Index (RSI) on the 14-day chart is 50.32, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.46, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.60%. Stochastics %K at 51.75% indicates the stock is a holding.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2025-02-28, growing by 0.13 million shares to a total of 3.9 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 3.77 million shares. There was a rise of 3.33%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 21, 2024 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $48 price target.
